Norges Bank Organogenesis Holdings Inc. Transaction History

Norges Bank

9 transactions

Quarter	Operation	Price Per share	shares change	shares Held
Q2 2024 Aug 14, 2024	BUY	$2.28 - $3.03 $1.1 Million - $1.46 Million	482,200 New	482,200 $1.35 Million
Q4 2023 Feb 09, 2024	BUY	$1.97 - $4.21 $949,934 - $2.03 Million	482,200 New	482,200 $1.97 Million
Q3 2023 Nov 13, 2024	BUY	$2.34 - $4.43 $1.13 Million - $2.14 Million	482,200 New	482,200 $1.53 Million
Q1 2022 May 12, 2023	BUY	$6.47 - $9.57 $712,994 - $1.05 Million	110,200 New	110,200 $839,000
Q1 2022 May 09, 2022	SELL	$6.47 - $9.57 $2.16 Million - $3.2 Million	-334,600 Closed	0 $0
Q4 2021 Mar 09, 2022	BUY	$9.02 - $13.5 $3.02 Million - $4.52 Million	334,600 New	334,600 $3.09 Million
Q3 2021 Nov 14, 2022	BUY	$13.71 - $17.18 $4.59 Million - $5.75 Million	334,600 New	334,600 $4.77 Million
Q3 2021 Nov 05, 2021	SELL	$13.71 - $17.18 $6.19 Million - $7.76 Million	-451,500 Closed	0 $0
Q2 2021 Aug 15, 2022	BUY	$14.92 - $23.23 $6.74 Million - $10.5 Million	451,500 New	451,500 $7.5 Million

117

63.2M

25K

23.2K

Ticker ORGO
Exchange NASDAQ
Sector Healthcare
Industry Drug Manufacturers—Specialty & Generic
Shares Outstandng 130,888,000
Market Cap $406M
Description
Organogenesis Holdings Inc., a regenerative medicine company develops, manufactures, and commercializes solutions for the advanced wound care, and surgical and sports medicine markets in the United States. The company's advanced wound care products include Affinity, an amniotic membrane wound covering in which viable cells growth factors/cytokin...

Get notified when there are updates to the investment portfolio of Norges Bank, based on Form 13F filings with the SEC.

Stay updated on Norges Bank with notifications on news.